Quest Diagnostics (DGX) Tops Q4 EPS by 4c, Beats on Revenue; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share
February 1, 2024 6:45 AM ESTFourth quarter revenues of $2.29 billion, down 1.9% from 2022Fourth quarter reported diluted earnings per share ("EPS") of $1.70, up 95.4% from 2022; and adjusted diluted EPS of $2.15, up 8.6% from 2022Fourth quarter base business revenues of $2.25 billion, up 4.7% from 2022Fourth quarter COVID-19 testing revenues of $37 million, down 79.8% from 2022Full year revenues of $9.25 billion, down 6.4% from 2022Full year reported diluted EPS of $7.49, down 6.0% from 2022; and adjusted diluted EPS of $8.71, down 12.5% from 2022Full year base business revenues of... More
